ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 523 out of 2061

$551K Total Retail Price of All Prescriptions

Rank: 580 out of 2061

436 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 8,459 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 531 490 1 1
LISINOPRIL 443 408 2 2
AMLODIPINE BESYLATE 437 405 3 4
ATORVASTATIN CALCIUM 363 331 4 8
LEVOTHYROXINE SODIUM 351 324 5 3
OMEPRAZOLE 267 246 6 5
HYDROCHLOROTHIAZIDE 251 226 7 12
HYDROCODONE-ACETAMINOPHEN 225 196 S3 8 10
ATENOLOL 208 205 9 13
GLIMEPIRIDE 190 172 10 33
METOPROLOL SUCCINATE 155 145 11 19
ALENDRONATE SODIUM 149 145 12 25
PANTOPRAZOLE SODIUM 138 101 13 45
LOSARTAN POTASSIUM 137 135 14 17
POTASSIUM CHLORIDE 117 105 15 16
METFORMIN HCL ER 116 113 16 71
METOPROLOL TARTRATE 109 108 17 7
FUROSEMIDE 107 90 18 6
METFORMIN HCL 100 88 19 9
SERTRALINE HCL 95 76 20 21
ALLOPURINOL 95 95 20 28
TAMSULOSIN HCL 93 90 22 30
ZETIA 92 92 23 68
KLOR-CON M20 90 86 24 47
CRESTOR 88 81 25 31
CITALOPRAM HBR 87 81 26 20
AZITHROMYCIN 84 77 27 34
PRAVASTATIN SODIUM 81 72 28 14
PRILOSEC OTC 81 68 28 345
OXYCODONE-ACETAMINOPHEN 79 70 S2 30 36
FLUTICASONE PROPIONATE 74 70 31 43
MELOXICAM 73 39 32 44
ADVAIR DISKUS 73 60 32 57
ZOLPIDEM TARTRATE 71 68 34 23
CARVEDILOL 70 62 35 22
TRIAMTERENE-HCTZ 70 53 35 38
DONEPEZIL HCL 69 69 37 24
LIPITOR 67 66 38 70
LANSOPRAZOLE 62 62 39 139
PROAIR HFA 61 36 40 40
GABAPENTIN 58 52 41 15
ALPRAZOLAM 56 56 42 85
BUMETANIDE 53 43 43 136
DIOVAN HCT 53 53 43 99
LEVOFLOXACIN 51 39 45 111
CELEBREX 50 38 46 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 43 46 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.